Literature DB >> 528983

Amantadine-resistant and -sensitive influenza A strains and recombinants.

C Scholtissek, G P Faulkner.   

Abstract

Several influenza A strains and recombinants of fowl plague virus (FPV) with a known gene constellation were tested for amantadine sensitivity under two different experimental conditions. In a haemagglutinin yield analysis of a single growth cycle experiment FPV was found to be highly sensitive to amantadine, while in the plaque reduction and inhibition test it was highly resistant. With the A3 Hong Kong and equi 2 strains the opposite observation was made. The A2 Singapore strain was sensitive while Ao PR8 was resistant in both tests. In the haemagglutinin yield analysis of a single growth cycle all recombinants carrying segment 4 (HA) of the resistant strain were resistent against amantadine, independent of the derivation of the other genes. In the plaque reduction and inhibition test recombinants carrying the haemagglutinin of the sensitive strain were either resistant or sensitive depending on the gene constellation. Drug sensitivity was transferred by the combination of segments 5 (NP) and 6 (NA). Segment 7 (M) of certain sensitive strains seems to counteract this effect. The results are compatible with the concept that amantadine resistance or sensitivity is not confined to a single gene product or a single mechanism.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 528983     DOI: 10.1099/0022-1317-44-3-807

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  15 in total

1.  Influenza virus strains with a fusion threshold of pH 5.5 or lower are inhibited by amantadine. Brief report.

Authors:  W E Beyer; R W Ruigrok; H van Driel; N Masurel
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

2.  Rescue of vector-expressed fowl plague virus hemagglutinin in biologically active form by acidotropic agents and coexpressed M2 protein.

Authors:  M Ohuchi; A Cramer; M Vey; R Ohuchi; W Garten; H D Klenk
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

3.  In vivo anti-influenza virus activity of a zinc finger peptide.

Authors:  A K Judd; A Sanchez; D J Bucher; J H Huffman; K Bailey; R W Sidwell
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

4.  The amantadine-sensitivity of recombinant and parental influenza virus strains.

Authors:  M Hamzawi; R Jennings; C W Potter
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

5.  Antiviral activity of sodium 5-aminosulfonyl-2,4-dichlorobenzoate (M12325).

Authors:  H Ohnishi; K Yamaguchi; S Shimada; S Himuro; Y Suzuki
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

6.  Comparative activity of amantadine and ribavirin against influenza virus in vitro: possible clinical relevance.

Authors:  M J Browne; M Y Moss; M R Boyd
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

7.  Current status of amantadine and rimantadine as anti-influenza-A agents: memorandum from a WHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

8.  Amantadine inhibits an early, M2 protein-dependent event in the replication cycle of avian influenza (H7) viruses.

Authors:  A P Kendal; H D Klenk
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

9.  The influence of Norakin on the reproduction of influenza A and B viruses.

Authors:  H Heider; S Markushin; C Schroeder; Y Ghendon
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

10.  Specific structural alteration of the influenza haemagglutinin by amantadine.

Authors:  R J Sugrue; G Bahadur; M C Zambon; M Hall-Smith; A R Douglas; A J Hay
Journal:  EMBO J       Date:  1990-11       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.